SCHEMBL4594746

SCHEMBL4594746

COC(=O)c1ccc(Nc2ccc3ccccc3c2OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
SIRT2 Q8IXJ6 1/20 0.52
PDE5A O76074 1/20 0.49
ABCC1 P33527 1/20 0.49
ABCG2 Q9UNQ0 1/20 0.49
MAPT P10636 7/20 0.47
TP53 P04637 3/20 0.47
ALDH1A1 P00352 4/20 0.47
CDC25A P30304 1/20 0.47
CDC25B P30305 1/20 0.47
RAB9A P51151 3/20 0.47
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
HPGD P15428 4/20 0.45
NPSR1 Q6W5P4 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
GAA P10253 2/20 0.45
TDP1 Q9NUW8 2/20 0.44
MITF O75030 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4594439 0.89 EGFR (0.50) KDM4EABCC1ABCG2MAPTALDH1A1
SCHEMBL4594901 0.85 KDM4E (0.58) KDM4ESIRT2PDE5AABCC1ABCG2
SCHEMBL4594357 0.83 RAB9A (0.63) KDM4ESIRT2PDE5AABCC1ABCG2
SCHEMBL4594726 0.82 ALDH1A1 (0.55) KDM4EMAPTTP53ALDH1A1CDC25B
SCHEMBL4593661 0.80 RAB9A (0.51) KDM4EABCG2MAPTTP53ALDH1A1
SCHEMBL5003682 0.79 AKR1C3 (0.45) KDM4EMAPTALDH1A1CDC25BRAB9A
SCHEMBL4594364 0.78 CDC25B (0.62) KDM4ESIRT2PDE5AABCC1ABCG2
SCHEMBL4594777 0.77 SIRT2 (0.57) KDM4ESIRT2PDE5AABCC1ABCG2
SCHEMBL2811271 0.74 RAB9A (0.62) KDM4ESIRT2MAPTTP53ALDH1A1
SCHEMBL9366126 0.74 KDM4E (0.43) KDM4EMAPTTP53ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US claimed
EP-1937243-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 2008-07-02 EP claimed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO claimed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation APP, BACE1, SNCA KDM4E 4789/4885SIRT2 2073/4885PDE5A 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.